Are you Dr. Wheeler?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 9 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
601 Elmwood Ave., Box 645
Rochester, NY 14642Phone+1 585-275-6177- Is this information wrong?
Summary
- Dr. Thurman Wheeler, MD is a board certified neurologist in Rochester, New York. He is currently licensed to practice medicine in New York, Massachusetts, and California. He is affiliated with Massachusetts General Hospital and is an Assistant Professor at University of Rochester School of Medicine & Dentistry.
Education & Training
- Johns Hopkins UniversityFellowship, Clinical Neurophysiology, 1999 - 2000
- University of WashingtonResidency, Neurology, 1996 - 1999
- University of Washington School of MedicineClass of 1995
Certifications & Licensure
- CA State Medical License 2001 - Present
- MA State Medical License 2013 - 2024
- NY State Medical License 2005 - 2014
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Extracellular RNA Biomarkers of Duchenne Muscular Dystrophy Start of enrollment: 2019 Nov 30
Publications & Presentations
PubMed
- Correction of Clcn1 alternative splicing reverses muscle fiber type transition in mice with myotonic dystrophy.Ningyan Hu, Eunjoo Kim, Layal Antoury, Thurman M Wheeler> ;Nature Communications. 2023 Apr 7
- 15 citationsAntisense oligonucleotide and adjuvant exercise therapy reverse fatigue in old mice with myotonic dystrophyNingyan Hu, Eunjoo Kim, Layal Antoury, Jia Li, Paloma Gonzalez-Perez, Seward B. Rutkove, Thurman M. Wheeler> ;Molecular Therapy. Nucleic Acids. 2021 Mar 5
- Urine mRNA to identify a novel pseudoexon causing dystrophinopathy.Layal Antoury, Ningyan Hu, Basil T. Darras, Thurman M. Wheeler> ;Annals of Clinical and Translational Neurology. 2019 May 17
- Join now to see all
Press Mentions
- Fluorescence Light up Potential Antisense Oligo Drugs for MDJanuary 1st, 2019
- Fluorescent Muscular Dystrophy Mouse Lights up Potential Antisense Oligo DrugsDecember 13th, 2018
- New Mouse Model May Speed Identification of Promising Muscular Dystrophy TherapiesDecember 12th, 2018
- Join now to see all
Hospital Affiliations
- Massachusetts General HospitalBoston, Massachusetts